Newcastle University Biosciences Institute, Wolfson Childhood Cancer Research Centre, Newcastle University, Level 6, Herschel Building, Brewery Lane, Newcastle upon Tyne NE1 7RU, U.K.
Biochem J. 2022 Jun 17;479(11):1121-1126. doi: 10.1042/BCJ20220023.
Numerous studies, published over many years, have established the key role that the IκB kinase (IKK) subunits, α and β, play in regulating the Nuclear Factor κB (NF-κB) pathway. This research generally concluded that their functions can be separated, with IKKβ being the critical regulator of the canonical NF-κB pathway, while IKKα functions as the key activating kinase for the non-canonical pathway. However, other roles for these kinases have been described and several reports concluded that this separation of their functions may not always be the case. This commentary discusses the recent report by Biochem J. 479, 305-325, who elegantly demonstrate that in KRAS driven colorectal cancer cell lines, IKKα is an important regulator of the canonical NF-κB pathway. As is so often the case with trying to understand the complexity of NF-κB signalling, cellular context is everything.
多年来发表的众多研究已经确定了 IκB 激酶 (IKK) 亚基 α 和 β 在调节核因子 κB (NF-κB) 途径中所起的关键作用。这项研究普遍得出结论,它们的功能可以分开,IKKβ 是经典 NF-κB 途径的关键调节因子,而 IKKα 则作为非经典途径的关键激活激酶。然而,这些激酶的其他作用也已被描述,并且有几份报告得出结论,它们的功能并不总是可以这样分开。这篇评论讨论了最近发表在 Biochem J. 479, 305-325 上的一篇报告,该报告巧妙地证明了在 KRAS 驱动的结直肠癌细胞系中,IKKα 是经典 NF-κB 途径的重要调节因子。正如在试图理解 NF-κB 信号传导的复杂性时经常发生的那样,细胞环境至关重要。